These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 10622285)
41. A conformationally sensitive GHR [growth hormone (GH) receptor] antibody: impact on GH signaling and GHR proteolysis. Jiang J; Wang X; He K; Li X; Chen C; Sayeski PP; Waters MJ; Frank SJ Mol Endocrinol; 2004 Dec; 18(12):2981-96. PubMed ID: 15345746 [TBL] [Abstract][Full Text] [Related]
42. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B. Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797 [TBL] [Abstract][Full Text] [Related]
43. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Yamauchi T; Ueki K; Tobe K; Tamemoto H; Sekine N; Wada M; Honjo M; Takahashi M; Takahashi T; Hirai H; Tushima T; Akanuma Y; Fujita T; Komuro I; Yazaki Y; Kadowaki T Nature; 1997 Nov; 390(6655):91-6. PubMed ID: 9363897 [TBL] [Abstract][Full Text] [Related]
44. Activation of growth hormone receptor delivers an antiapoptotic signal: evidence for a role of Akt in this pathway. Costoya JA; Finidori J; Moutoussamy S; Seãris R; Devesa J; Arce VM Endocrinology; 1999 Dec; 140(12):5937-43. PubMed ID: 10579361 [TBL] [Abstract][Full Text] [Related]
45. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling. Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851 [TBL] [Abstract][Full Text] [Related]
46. Recombinant analogues of prolactin, growth hormone, and placental lactogen: correlations between physical structure, binding characteristics, and activity. Gertler A J Mammary Gland Biol Neoplasia; 1997 Jan; 2(1):69-80. PubMed ID: 10887521 [TBL] [Abstract][Full Text] [Related]
47. Termination of growth hormone pulse-induced STAT5b signaling. Gebert CA; Park SH; Waxman DJ Mol Endocrinol; 1999 Jan; 13(1):38-56. PubMed ID: 9892011 [TBL] [Abstract][Full Text] [Related]
48. Molecular cloning of the bovine prolactin receptor and distribution of prolactin and growth hormone receptor transcripts in fetal and utero-placental tissues. Scott P; Kessler MA; Schuler LA Mol Cell Endocrinol; 1992 Nov; 89(1-2):47-58. PubMed ID: 1338725 [TBL] [Abstract][Full Text] [Related]
49. Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling. He K; Wang X; Jiang J; Guan R; Bernstein KE; Sayeski PP; Frank SJ Mol Endocrinol; 2003 Nov; 17(11):2211-27. PubMed ID: 12920237 [TBL] [Abstract][Full Text] [Related]
50. Partial purification of somatotropin receptors from pig liver: they arise from a single somatotropin receptor messenger RNA transcript. Louveau I; Etherton TD J Anim Sci; 1992 Nov; 70(11):3421-8. PubMed ID: 1459902 [TBL] [Abstract][Full Text] [Related]
51. Nuclear translocation and retention of growth hormone. Mertani HC; Raccurt M; Abbate A; Kindblom J; Törnell J; Billestrup N; Usson Y; Morel G; Lobie PE Endocrinology; 2003 Jul; 144(7):3182-95. PubMed ID: 12810575 [TBL] [Abstract][Full Text] [Related]
52. Stimulation of human trophoblast invasion by placental growth hormone. Lacroix MC; Guibourdenche J; Fournier T; Laurendeau I; Igout A; Goffin V; Pantel J; Tsatsaris V; Evain-Brion D Endocrinology; 2005 May; 146(5):2434-44. PubMed ID: 15718272 [TBL] [Abstract][Full Text] [Related]
53. Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation. Wang X; Darus CJ; Xu BC; Kopchick JJ Mol Endocrinol; 1996 Oct; 10(10):1249-60. PubMed ID: 9121492 [TBL] [Abstract][Full Text] [Related]
54. Roles of JAK kinase in human GM-CSF receptor signals. Watanabe S; Itoh T; Arai K Leukemia; 1997 Apr; 11 Suppl 3():76-8. PubMed ID: 9209304 [TBL] [Abstract][Full Text] [Related]
55. Postreceptor signalling of growth hormone and prolactin and their effects in the differentiated insulin-secreting cell line, INS-1. Sekine N; Ullrich S; Regazzi R; Pralong WF; Wollheim CB Endocrinology; 1996 May; 137(5):1841-50. PubMed ID: 8612523 [TBL] [Abstract][Full Text] [Related]
56. The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the Pro-B Ba/F3 cell line. Baixeras E; Jeay S; Kelly PA; Postel-Vinay MC Endocrinology; 2001 Jul; 142(7):2968-77. PubMed ID: 11416018 [TBL] [Abstract][Full Text] [Related]
58. Differential effects of maternal ovine placental lactogen and growth hormone (GH) administration on GH receptor, insulin-like growth factor (IGF)-1 and IGF binding protein-3 gene expression in the pregnant and fetal sheep. Currie MJ; Bassett NS; Breier BH; Klempt M; Min SH; Mackenzie DD; McCutcheon SN; Gluckman PD Growth Regul; 1996 Sep; 6(3):123-9. PubMed ID: 8894644 [TBL] [Abstract][Full Text] [Related]
59. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling. Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778 [TBL] [Abstract][Full Text] [Related]
60. Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts. King AP; Carter-Su C Endocrinology; 1995 Nov; 136(11):4796-803. PubMed ID: 7588209 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]